Peer-influenced content. Sources you trust. No registration required. This is HCN.
British Medical Journal
The study underscores the potential influence of pharmaceutical industry payments on the delivery of non-recommended or low value interventions in cancer treatment. It highlights the need for increased transparency and scrutiny in the financial relationships between physicians and the industry.
Hematology/Oncology November 6th 2023
OBR Oncology
The recent suspension of Dr. Benjamin Neel, former director of NYU’s Perlmutter Cancer Center, underscores the importance of academic integrity in the medical field. As healthcare professionals, it’s crucial to uphold the highest standards of conduct in our research.
Oncology, Medical November 6th 2023
The increasing acquisition of oncology practices by private equity firms poses new challenges to healthcare ethics and operations. Stay informed and be prepared to advocate for patient-centric reforms.
Hematology/Oncology October 9th 2023
Annals of Internal Medicine
The ACP’s new guidelines on “grateful patient” fundraising highlight the ethical complexities of involving physicians in fundraising efforts. Understand the implications for your practice and patient relationships.
All Specialties October 4th 2023
MDLinx
The Hein case has ignited a national debate on the ethics of gender-affirming care for minors, raising questions about informed consent and the role of healthcare providers in these complex decisions.
The Epoch Times
The FDA’s approval of brexpiprazole for Alzheimer’s-related agitation has sparked a debate over its efficacy and safety, raising concerns that extend beyond this specific drug to the integrity of the regulatory process itself.
Geriatrics October 3rd 2023